| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 45.5× | −1.7× | |
| Price / Book | 3.6× | 2.0× | |
| Price / Sales | 14.7× | 3.9× | |
| Price / Free cash flow | 14.1× | −1.6× | |
| EV / EBITDA | 26.5× | −1.2× | |
| Earnings yield | 2.2% | −14.6% | |
| Free cash flow yield | 7.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.34 | −0.77% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $252.00 | −1.39% | $607.29B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.11 | −0.46% | $502.06B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.61 | +0.29% | $361.38B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.43 | −0.36% | $358.8B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $149.92 | −0.46% | $277.34B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.09 | −0.19% | $256.04B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.13 | −0.85% | $252.96B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $429.15 | −0.77% | $232.01B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.10 | −0.70% | $192.31B | 22.8× | 37.5% | +32.0% |
